Fidelity Investments’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-96
| Closed | -$105 | – | 5365 |
|
2024
Q4 | $105 | Sell |
96
-189
| -66% | -$207 | ﹤0.01% | 5098 |
|
2024
Q3 | $216 | Sell |
285
-7,148
| -96% | -$5.42K | ﹤0.01% | 5024 |
|
2024
Q2 | $9.22K | Buy |
7,433
+4,489
| +152% | +$5.57K | ﹤0.01% | 4354 |
|
2024
Q1 | $5.56K | Sell |
2,944
-3,861
| -57% | -$7.3K | ﹤0.01% | 4469 |
|
2023
Q4 | $18K | Buy |
6,805
+5,021
| +281% | +$13.3K | ﹤0.01% | 3998 |
|
2023
Q3 | $4.1K | Sell |
1,784
-3,108
| -64% | -$7.15K | ﹤0.01% | 4379 |
|
2023
Q2 | $17.9K | Buy |
4,892
+465
| +11% | +$1.7K | ﹤0.01% | 3913 |
|
2023
Q1 | $15.8K | Buy |
4,427
+3,943
| +815% | +$14.1K | ﹤0.01% | 3945 |
|
2022
Q4 | $1.38K | Buy |
+484
| New | +$1.38K | ﹤0.01% | 4594 |
|
2022
Q3 | – | Sell |
-10
| Closed | – | – | 4925 |
|
2022
Q2 | $0 | Sell |
10
-1,101
| -99% | – | ﹤0.01% | 4978 |
|
2022
Q1 | $5K | Buy |
+1,111
| New | +$5K | ﹤0.01% | 4420 |
|